Svenska
English
Start
About us
Operations
Board of Directors
Management
Team
Collaboration
Career
Technology
Tolerogens
Program
Autoimmune disease
Rare disease
Myasthenia Gravis
SME Instrument
Pipeline
News
All press releases
Events
Media
Investors
Rights Issue 2023
Reports
Corporate governance
Share information
Investor Relations
Contact
Share price:
Latest: (SEK)
High: (SEK)
Nasdaq
News
All press releases
Events
Media
Toleranzia_AB_Arsredovisning_och_Revisionsberattelse_2023_2
5 May - 2024
Toleranzia_AB_Arsredovisning_och_Revisionsberattelse_2023_2
« Older post
Subscribe to Toleranzia’s news here
Start
About us
▼
Operations
Board of Directors
Management
Team
Collaboration
Career
Technology
▼
Tolerogens
Program
▼
Autoimmune disease
Rare disease
Myasthenia Gravis
SME Instrument
Pipeline
News
▼
All press releases
Events
Media
Investors
▼
Rights Issue 2023
Reports
Corporate governance
Share information
Investor Relations
Contact
Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida. Om du fortsätter att använda den här webbplatsen kommer vi att anta att du godkänner detta.
Ok
